Business context and reporting period
Docusign, Inc. provides electronic-signature, contract lifecycle management and agreement-workflow products, including its newly launched Intelligent Agreement Management (IAM) platform. This Form 10-Q covers the three months ended April 30, 2024—Docusign’s first quarter of fiscal 2025—and compares results with the same period in 2023. Amounts below are in U.S. dollars.
Key financial metrics
| Metric | Q1 FY2025 | Q1 FY2024 |
|---|---|---|
| Revenue | $709.6 million | $661.4 million |
| Gross profit / GAAP gross margin | $560.2 million / 78.9% | $524.9 million / 79.4% |
| Operating income (loss) / margin | $22.6 million / 3.2% | $(4.7) million / (0.7)% |
| Net income | $33.8 million | $0.5 million |
| Diluted EPS | $0.16 | $0.00 |
| Cash from operating activities | $254.8 million | $233.6 million |
| Free cash flow (non-GAAP) | $232.1 million | $214.6 million |
| Billings (non-GAAP) | $709.5 million | $674.8 million |
Subscription revenue, approximately 97% of total revenue, rose 8% to $691.5 million. Professional services and other revenue declined 18% to $18.2 million. GAAP gross margin was nearly flat year over year; subscription gross margin declined to 81.7% from 83.0%. Non-GAAP operating income increased to $202.1 million from $175.8 million, and non-GAAP net income was $172.8 million versus $150.2 million.
Cash and cash equivalents were $817.4 million at April 30, 2024; short-term investments were $269.4 million and long-term investments were $139.1 million, or approximately $1.23 billion in combined cash, cash equivalents and investments. The cash-flow statement reports $822.8 million of cash, cash equivalents and restricted cash. Current assets were $1.49 billion and current liabilities $1.60 billion. Contract liabilities, largely deferred customer revenue, were $1.34 billion. The company had no borrowings under its $500 million revolving credit facility, which matures in January 2026, and reported covenant compliance. Convertible notes had been repaid in fiscal 2024.
Changes versus the prior comparable period
- Revenue increased 7%; management attributed subscription growth to customer additions, customer expansion and commercial and enterprise sales.
- Operating results improved from a loss to income. General and administrative expense fell 12%, mainly because the prior-year period included additional stock-based compensation related to an executive transition.
- Research and development expense rose 16%, reflecting workforce investment and higher stock-based compensation. Subscription cost of revenue rose 16%, including higher cloud-hosting and personnel costs.
- Operating cash flow increased about 9%, while investing cash flow shifted to a $60.8 million use from $7.8 million provided, principally reflecting net purchases of marketable securities and property and equipment.
- Share repurchases increased to $149.1 million for 2.5 million shares, versus $40.5 million for 0.7 million shares a year earlier.
- International revenue grew to $196.9 million from $168.3 million and represented 28% of revenue, compared with 25%.
Outlook, risks and unusual items
- The filing provides no quantified revenue or earnings guidance. Management said IAM’s rollout and new pricing model would be gradual during fiscal 2025; a user-based subscription with transaction-based add-ons was expected to be offered beginning in the second quarter of fiscal 2025. E-signature is expected to remain the majority of revenue for the foreseeable future.
- A new restructuring plan incurred $29.1 million of charges in the quarter, primarily employee termination benefits; execution was expected to be substantially complete by the end of Q2 FY2025. The plan followed a prior restructuring substantially completed in fiscal 2024.
- On May 31, 2024, after quarter-end, Docusign completed its acquisition of Lexion for approximately $165 million in cash, subject to adjustments. Purchase accounting was not yet complete in the filing.
- In May 2024, the board authorized up to an additional $1.0 billion of stock repurchases. This is discretionary and has no mandated end date.
- Management said sufficient sustained profitability could support a release of some or all of the U.S. deferred-tax valuation allowance during fiscal 2025. A release could reduce tax expense by an estimated $750–$850 million, but timing and amount are uncertain and depend on actual profitability and other factors.
- Material risks include competition and customer retention, acceptance and execution of IAM and AI offerings, cybersecurity and service availability, macroeconomic conditions, privacy and regulatory requirements, and litigation. The securities class action is proceeding after denial of a motion to dismiss; related derivative suits have been filed. Former CEO Daniel Springer’s arbitration hearing concluded in March 2024, with a final order expected on or before July 12, 2024.
- Stock-based compensation was $142.5 million, about 20% of quarterly revenue. It is excluded from Docusign’s cited non-GAAP operating and net income measures.
Important facts for investors to verify
- Whether subscription growth and billings sustain momentum, particularly as IAM pricing and adoption develop.
- Whether improving GAAP profitability continues after restructuring charges and substantial stock-based compensation.
- Cash deployment and liquidity following the Lexion acquisition and expanded repurchase authorization; repurchases are discretionary.
- Progress toward sustained U.S. profitability and any resulting valuation-allowance release, which is not assured.
- Developments in the securities and derivative litigation and the former CEO arbitration.
- The acquisition’s final purchase accounting and any subsequent information on Lexion’s contribution to results.